"O Hospital Araújo Jorge (HAJ) é a primeira e a maior unidade operacional da ACCG. É uma unidade de saúde privada e filantrópica, atendendo em média 80% dos pacientes pelo Sistema Único de Saúde(SUS). O HAJ atende pacientes de todas as idades, oferecendo tratamento para todos os tipos de câncer com os mais modernos recursos da atualidade. O Hospital Araújo Jorge é considerado referência no tratamento do câncer no Centro-Oeste, mas também atende pacientes de outras regiões brasileiras, notadamente Norte e Nordeste (Acre, Pará, Rondônia, Tocantins, Bahia)."

During the past decade, Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás" #1 collaborator was "Araujo Jorge Hospital" with 1 trials as a collaborator and "Associaçao de Combate ao Cancer em Goias" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás" are "Breast Cancer" (2 trials), "Advanced Solid Tumor" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Complications" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás" in a lesser frequency.

Most popular intervention types in "Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás" are "Drug" (4 trials), "Behavioral" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Erdafitinib" (3 trials), "Abiraterone Acetate" (1 trials), "Closed suction drainage" (1 trials), "Docetaxel" (1 trials) and "Fibroblast Growth Factor Receptor inhibitor Clinical Trial Assay (FGFRi CTA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás" are 4 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás has several departments that took part in Clinical trials: "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" - 16 trials